2006
DOI: 10.1016/s0140-6736(06)69044-2
|View full text |Cite
|
Sign up to set email alerts
|

Cholesterol gallstone disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

10
511
3
18

Year Published

2007
2007
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 605 publications
(564 citation statements)
references
References 124 publications
10
511
3
18
Order By: Relevance
“…Hypersecretion of cholesterol from liver with cholesterol supersaturation of bile represents the common defect in patients with cholesterol gallstones. 4,18,45 Furthermore, the 19H allele has also been associated with higher serum levels of cholesterol precursors (cholestanol, lathosterol), 23 indicating increased cholesterol biosynthesis, as has been observed in obese gallstone patients. 46,47 These findings taken together suggest low intestinal cholesterol absorption and high compensatory cholesterol biosynthesis in carriers of the ABCG8 D19H variant, as hypothesized previously by Gylling et al 23 Of note, the up-regulated cholesterol biosynthesis in these subjects explains the greater efficacy of HMG-CoA reductase inhibitors such as atorvastatin therapy in 19H carriers.…”
Section: Discussionmentioning
confidence: 86%
See 1 more Smart Citation
“…Hypersecretion of cholesterol from liver with cholesterol supersaturation of bile represents the common defect in patients with cholesterol gallstones. 4,18,45 Furthermore, the 19H allele has also been associated with higher serum levels of cholesterol precursors (cholestanol, lathosterol), 23 indicating increased cholesterol biosynthesis, as has been observed in obese gallstone patients. 46,47 These findings taken together suggest low intestinal cholesterol absorption and high compensatory cholesterol biosynthesis in carriers of the ABCG8 D19H variant, as hypothesized previously by Gylling et al 23 Of note, the up-regulated cholesterol biosynthesis in these subjects explains the greater efficacy of HMG-CoA reductase inhibitors such as atorvastatin therapy in 19H carriers.…”
Section: Discussionmentioning
confidence: 86%
“…[1][2][3][4] Although most gallstones are silent, 25% of gallstone carriers develop symptoms during life and have to undergo cholecystectomy, causing a substantial economic burden for the health care systems. 4,5 At present, the mechanisms of gallbladder stone formation are understood, but knowledge of genes that cause susceptibility to gallstones in humans is lacking. 6 Thus, the NIH Action Plan for Liver Disease Research 5 specified a major long-term research goal of identifying genetic factors that define populations at risk and might lead to new preventive and therapeutic strategies.…”
mentioning
confidence: 99%
“…Cholesterol gallstones may develop due to excessive secretion of cholesterol into the bile; if the ratio of biliary cholesterol to bile acids and phospholipids exceeds critical limits, the cholesterol may precipitate and form stones (5). A number of factors may contribute to biliary cholesterol supersaturation, including increases in cholesterol uptake from the circulation, increased cholesterol biosynthesis in the liver, or reduced catabolism of cholesterol to bile acids (23). Changes in the hepatic expression of genes that regulate these factors could significantly affect gallstone formation.…”
Section: Discussionmentioning
confidence: 99%
“…Hepatocellular carcinoma (HCC) is a major health problem worldwide, with approximately one million newly-diagnosed cases each year. 1 Recent advances in imaging modalities have permitted the detection of HCC at an early stage. However, despite extensive efforts to improve early diagnosis and treatment, only 10-30% of patients diagnosed with HCC are eligible for curative treatments.…”
Section: Referencesmentioning
confidence: 99%
“…The identification of specific canalicular membrane transporters involved in cholesterol (ABCG5/ABCG8), phosphatidylcholine (MDR3/ABCB4) and bile salt (ABCB11) secretion into bile has permitted the characterization of bile formation at a molecular level. 1 The gallbladder is also important, with factors such as bile stasis induced by gallbladder dysmotility and the presence of potent nucleating agents, chief amongst them mucin glycoproteins, playing essential roles. A detailed understanding of the physical-chemical interactions between lipid carriers in bile has also shed light on the mechanisms involved through the use of ternary bile salt/cholesterol/phospholipid phase diagrams in native and model biles.…”
mentioning
confidence: 99%